DB-1317

DB-1317 · DualityBio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DB-1317, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors [Phase 1]